Aptevo Therapeutics Inc. (APVO) vs Moolec Science S.A. (MLEC)
A side-by-side comparison of Aptevo Therapeutics Inc. and Moolec Science S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.85HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
MLEC
Moolec Science S.A.
$4.68HealthcareDelayed quote: Oct 6, 2026, 11:17 AM EDT
Total return — APVO vs MLEC
growth of $100 · dividends reinvested · last 6yAPVO -100.0% (-93.2%/yr)MLEC -99.7% (-61.4%/yr)MLEC compounded faster over this window
Log scale — wide-divergence pair
APVO MLEC
APVO vs MLEC: by the numbers
- •APVO is the larger company ($4M vs $3M market cap).
- •Both run net losses; APVO's is the smaller (0.00% vs -105.71% net margin).
Metrics side by side
Valuation
| Metric | APVO | MLEC |
|---|---|---|
| P/B ratio | 0.67 | N/A |
Profitability
| Metric | APVO | MLEC |
|---|---|---|
| Gross margin | 0.00% | 34.17% |
| Operating margin | 0.00% | -3.14% |
| Net margin | 0.00% | -105.71% |
| ROE | -437.15% | -89.85% |
| ROIC | -288.14% | -33.50% |
Growth (annualized)
| Metric | APVO | MLEC |
|---|---|---|
| Total return CAGR (5Y) | -95.30% | -68.13% |
Frequently asked
- How have APVO and MLEC total returns compared?
- Over the past 5 years, APVO delivered -95.30% and MLEC delivered -68.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.